has_role
organic heterocyclic compound
antipsychotic agent
carboxamide
amisulpride
0
369.17223
369.487
CiteXplore:22035899
pubmed:21822161
patent:BE872585
ChEMBL:489011
CiteXplore:21663752
SNOMEDCT:391761004
CiteXplore:21852060
kegg.drug:D07310
4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide
amisulprida
4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide
cas:71675-85-9
NTJOBXMMWNYJFB-UHFFFAOYSA-N
SNOMEDCT:321636003
amisulpride
CiteXplore:21822161
pubmed:21647545
CiteXplore:22121864
Aminosultopride
wikipedia.en:Amisulpride
pubmed:21852060
CiteXplore:21746752
pubmed:22250612
pubmed:21969105
patent:US4401822
CiteXplore:22241281
pubmed:21176108
pubmed:22059694
pubmed:21888613
CiteXplore:21886905
KEGG DRUG:D07310
pubmed:21845006
CiteXplore:21647545
A member of the class of benzamides resulting from the formal condensation of the carboxy group of 4-amino-5-(ethylsulfonyl)-2-methoxybenzoic acid with the primary amino group of 2-(aminomethyl)-1-ethylpyrrolidine. It is a potent, selective dopamine D<small><sub>2</sub></small> and D<small><sub>3</sub></small> receptor antagonist. It is an atypical antipsychotic/antischizophrenic agent with limited extrapyrimidal side effects.
hmdb:HMDB0015633
C17H27N3O4S
CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC
pubmed:21663752
4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide
pubmed:21886905
CiteXplore:21888613
reaxys:6876191
lincs.smallmolecule:LSM-1669
CiteXplore:21845006
pubmed:22035899
CiteXplore:21969105
CHEBI:64045
drugcentral:179
pubmed:21746752
InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)
4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide
CiteXplore:22059694
pubmed:22241281
CiteXplore:21176108
amisulpridum
pubmed:22121864
CiteXplore:22250612
drugbank:DB06288
chebi_ontology
NCIt:C83533